Zhitong Financial APP News, Laimei Pharmaceutical (300006.SZ) released the third quarter report of 2022, the company's operating income in the first three quarters was 671 million yuan, down 24.77% from the same period last year. The net loss attributable to the shareholders of the listed company is 37.373 million yuan. The net loss after deducting non-recurring profit and loss belonging to the shareholders of the listed company is 70.0773 million yuan. The basic earnings per share is 0.33 yuan.
莱美药业(300006.SZ)发布前三季度业绩，净亏损3737.3万元
300006.SZ posted a net loss of 37.373 million yuan for the first three quarters.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.